HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin-an Lu Selected Research

LDP-endostatin N-terminal fusion protein

10/2013Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin-an Lu Research Topics

Disease

3Neoplasm Metastasis (Metastasis)
10/2015 - 10/2013
2Neoplasms (Cancer)
08/2014 - 10/2013
1Insulin Resistance
07/2015
1Obesity
07/2015
1Glucose Intolerance
07/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2015
1Breast Neoplasms (Breast Cancer)
10/2013
1Carcinoma (Carcinomatosis)
10/2013

Drug/Important Bio-Agent (IBA)

2EndostatinsIBA
07/2015 - 10/2013
1Carboplatin (JM8)FDA LinkGeneric
10/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015
1Paclitaxel (Taxol)FDA LinkGeneric
10/2015
1Fluorouracil (Carac)FDA LinkGeneric
10/2015
1CytokinesIBA
10/2015
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2014
1Monoclonal AntibodiesIBA
08/2014
1Anti-Bacterial Agents (Antibiotics)IBA
10/2013
1LDP-endostatin N-terminal fusion proteinIBA
10/2013
1C 1027IBA
10/2013
1endostatin-LDP C-terminal fusion proteinIBA
10/2013
1Proteins (Proteins, Gene)FDA Link
10/2013

Therapy/Procedure

4Therapeutics
10/2015 - 10/2013
1Drug Therapy (Chemotherapy)
10/2015